Canadian govt move to plain language for drug labeling

17 June 2013

Canadian Health Minister Leona Aglukkaq has announced the launch of the Plain Language Labeling Initiative, which aims to improve the safe use of drugs by making drug labels and safety information easier to read and understand.

"Every day millions of Canadians rely on drugs to maintain and improve their health. While medications offer significant benefits, they can also carry some risks," said Minister Aglukkaq, adding: "I am pleased to announce that our government will be making plain language a requirement on drug packages in order to help prevent adverse drug reactions, medication errors and protect Canadian patients."

To work properly and reduce the chance of harm, drugs should be taken according to the information provided on the label or package. Yet, current drug product information can be confusing to follow. Too often, people experience unnecessary harms as a result of drug labels, packaging or names that may be hard to understand or they sound similar to other drugs. As many as 1 in 9 emergency rooms visits are related to drug adverse events, and as many as 68% of those are preventable.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Pharmaceutical